Lipocine is a biopharmaceutical company leveraging its proprietary technology platform to develop innovative products with effective oral delivery.
Our drug candidates represent enablement of differentiated, patient friendly oral options with favorable benefit to risk profiles which target large addressable markets with significant unmet medical needs.
Patient-friendly
Our products and product candidates represent convenient oral therapy options.
Favorable benefit-risk profile
Our pipeline is comprised of candidates offering favorable benefit to risk profiles.
Lip’ral is a proprietary technology based on lipidic composition, which forms an optimal drug nano dispersion in the gastrointestinal tract, enabling improved portal and/or lymphatic absorption of highly water-insoluble drugs. Our drug composition is designed for the most efficient oral performance and more resist to physiological variables.